Tirze vs sema — switching experiences and who should consider it

Opposite experience. Ran tirze 5 for 8 weeks after sema 1.0 plateaued, had worse nausea, same loss rate. Went back to sema 1.0 + slower eating pace and resumed losing. Not everyone needs the switch.

Sema never did anything meaningful for me. 2.4 for 6 months, 9lb total. Switched to tirze, lost 32lb in the same 6-month window at 10mg. My body apparently needs the GIP arm. Some people are GLP-1 responders, some need both. You don't know which you are until you try.

The mechanism-based heuristic: if you have strong metabolic dysfunction signals (high fasting insulin, high HOMA-IR, NAFLD, T2D), the GIP arm of tirze tends to add meaningful benefit. If your issue is purely behavioral/appetite and metabolic markers are normal, sema is usually sufficient and cheaper.

I switched for a different reason — availability. Sema supply was unreliable for about 4 months in my area, tirze was steady. Switched for logistics, stayed because it worked better subjectively.

Dose equivalence conversion people ask about: loose rule is tirze 5 ~ sema 1.0, tirze 10 ~ sema 2.0, tirze 15 ~ above sema max. Not exact, based on weight loss efficacy in head-to-head trials (SURMOUNT-5). Use it as a starting point, not a prescription.

Sulfur burp profile definitely different between the two. Sema gave me egg burps consistently. Tirze gives me nothing in that category. Mechanism probably related to gastric emptying kinetics differing slightly between the molecules.

Running microdose of both simultaneously as an experiment — 0.1mg sema + 1mg tirze weekly, split doses. Closer to once-every-3-days injection rhythm. Keeps both receptor systems lightly activated. Bloodwork is the best it's been in 10 years. N=1 and weird but I'll keep running it.

@microdose_glp1 cool experiment but worth noting — there's no trial data on dual-drug GLP-1 use, so you're in full N=1 territory. No reason to think it's dangerous if both are at microdose but also no reason to think it's additive on the effect side either.

@hexaclinic your mechanism framing matches my experience — my fasting insulin was 19 pre-switch, HOMA-IR was 4.1. Tirze slammed those. Sema hadn't budged them meaningfully in 18 months.

Cost was my switch driver — compounded tirze was cheaper in my state than sema. Same weight loss rate, ~$80/mo less. Sometimes the decision is just economics.

Can you switch mid-week or do you finish out a sema cycle first? Asking because I'm considering a switch and don't know if there's a washout needed.

@petal_push half-life overlap is fine — skip one sema week, take your first tirze dose on what would have been your sema day. No meaningful washout needed at the receptor level. Kinetics overlap is the feature not the bug.

The 'switching' frame presumes one drug is 'better.' More accurate: different drugs work better for different phenotypes. The right question isn't 'is tirze better than sema' — it's 'what metabolic phenotype am I and which tool fits it.' Trial and error is your N=1 phenotyping.

Add to this: starting dose matters when switching. Don't go from sema 2.4 to tirze 7.5 'equivalent' on day one — step up from tirze 2.5 or 5 as a buffer. Your GI tract is not identically adapted to the two drugs.

This thread is my decision tree for the next 6 months. Saving every reply.

Worth adding for the record: if you're deciding between these, insurance and prescriber access are real variables. The 'best' drug on paper that you can't afford consistently is worse than the 'second best' drug you can maintain for 18 months. Adherence is a molecule too.